Vetter Pharma is a global pharmaceutical service provider specializing in the aseptic manufacture of injectable medicines. Established in 1950, the company has grown to become a leading player in the Biotechnology, Manufacturing, and Pharmaceutical industries and operates from state-of-the-art production sites in Europe and the United States. With a workforce of 6,000 employees, Vetter Pharma collaborates with pharmaceutical and biotechnology companies of all sizes, offering comprehensive support from active ingredient development through to delivery. The company's commitment to improving the lives of patients is underpinned by a strong sense of responsibility, teamwork, openness, and commitment. As a family business, Vetter Pharma prioritizes personal and professional development, underlining its dedication to building a cohesive team where every contribution counts. For more information, visit www.vetter-pharma.com.
There is no investment information
No recent news or press coverage available for Vetter Pharma.